|

Parkinson's Disease Clinical Trials in Tennessee

15 recruiting studies across 2 cities

Browse by City

Nashville
12 trials
Memphis
3 trials

All Trials in Tennessee

Phase
Trial Phase Dist.
Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's DiseasePhase 2<1 mi
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor ComplicationsPhase 3<1 mi
A Study of Buntanetap in Participants With PDPhase 2/3<1 mi
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePhase 2<1 mi
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseasePhase 3<1 mi
Physiological Brain Atlas Development—<1 mi
Corticostriatal Contributions to Parkinson's Disease Cognitive ImpairmentN/A<1 mi
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)Phase 2<1 mi
Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)Phase 1/2<1 mi
Pimavanserin vs. Quetiapine for Treatment of Parkinson's PsychosisPhase 4<1 mi
Parkinson's Foundation PD GENEration Genetic Registry—<1 mi
Neurophysiology of Reward Signaling in Parkinson's DiseaseN/A<1 mi
Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease—<1 mi
Use of CereGate Therapy for Freezing of Gait in PDN/A<1 mi
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry—<1 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.